Products

TabSwipe

TabSwipe v1.2

tabswipe.app Productivity & Collaboration / Desktop & Window Management

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
One-time
No monthly subscription pricing
Creators
Marcus
No social account linked
Launched
6mo ago
2026-06-04 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    ChromeOS-style continuous tab switching for Mac

    Jun 4 · 6mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct32%
  • Organic Search27%
  • Referrals13%
  • Display Ads7%
  • Other22%

Countries

  • United States85%
  • India15%

Search

Domain authority —Domain registered 2026-03-18

KeywordMonthly volume
how to switch tabs on mac1,060
how to quickly switch tabs on mac810
tabswipe670
move between browser tabs mac510
can i change chorome tab by trackingpad gesture on mac50

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: We offer a 3-day free trial so you can experience the native haptics and fluid gestures before you buy. · Observed 2026-11-02 · Source page

Pages & changes

Tracked since 2026-06-04

Key pages

Weekly snapshots
Home
tabswipe.app/ Snapshot 2026-11-03

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does TabSwipe get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is TabSwipe and what platforms does it support?
TabSwipe is catalogued under Desktop & Window Management: TabSwipe v1.2. Supported platforms: Web.

Related products in this category

Productivity & Collaboration / Desktop & Window Management

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.